| Mrs Caroline Lasewicz, ARNP | |
|
3 Alumni Dr Ste 401, Exeter, NH 03833-2123 | |
| (603) 778-0557 | |
| (603) 778-1669 |
| Full Name | Mrs Caroline Lasewicz |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 23 Years |
| Location | 3 Alumni Dr Ste 401, Exeter, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194835009 | NPI | - | NPPES |
| 30341068 | Medicaid | NH | |
| 40Y002876NH01 | Other | NH | ANTHEM BC/BS |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Physicians Llc | 2769563253 | 234 |
News Archive
Pediatric high-grade glioma is the primary cause of cancer death in children. Genesis of these tumors is believed to be driven by mutations in proteins that disrupt fundamental mechanisms governing the development of the human brain.
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.
There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.
› Verified 9 days ago
| Entity Name | Core Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336330588 PECOS PAC ID: 2769563253 Enrollment ID: O20080123000205 |
News Archive
Pediatric high-grade glioma is the primary cause of cancer death in children. Genesis of these tumors is believed to be driven by mutations in proteins that disrupt fundamental mechanisms governing the development of the human brain.
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.
There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Caroline Lasewicz, ARNP 7 Holland Way Fl 1, Exeter, NH 03833-2997 Ph: (603) 778-0557 | Mrs Caroline Lasewicz, ARNP 3 Alumni Dr Ste 401, Exeter, NH 03833-2123 Ph: (603) 778-0557 |
News Archive
Pediatric high-grade glioma is the primary cause of cancer death in children. Genesis of these tumors is believed to be driven by mutations in proteins that disrupt fundamental mechanisms governing the development of the human brain.
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.
There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.
› Verified 9 days ago